Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Lowe

Showing results (161-170 of 321) with videos related to

Pageof 33
Sort By:
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2014
p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like stateSerif Senturk, Zhan Yao, Matthew Camiolo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Functional interrogation uncovers a critical role for a high-plasticity cell state in lung adenocarcinomaJason E Chan, Chun-Hao Pan, Jonathan Rub, et al.
Cell|July 4, 2006
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approachLars Zender, Mona S Spector, Wen Xue, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2006
Loss of p53 impedes the antileukemic response to BCR-ABL inhibitionHans-Guido Wendel, Elisa de Stanchina, Enriqué Cepero, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1)Seiji Kondo, Ying Lu, Michael Debbas, et al.
Blood|January 14, 2014
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMichael Bots, Inge Verbrugge, Benjamin P Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2024
Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 inductionXin Zhao, Bin Liu, William N William, et al.
Nature Genetics|March 31, 2015
Cooperative loss of RAS feedback regulation drives myeloid leukemogenesisZhen Zhao, Chi-Chao Chen, Cory D Rillahan, et al.
Cancer Discovery|May 10, 2019
A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1Evangelia Loizou, Ana Banito, Geulah Livshits, et al.
Pageof 33

Showing results (161-170 of 321) with videos related to

Sort By:
Pageof 33
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2014
p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like stateSerif Senturk, Zhan Yao, Matthew Camiolo, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Functional interrogation uncovers a critical role for a high-plasticity cell state in lung adenocarcinomaJason E Chan, Chun-Hao Pan, Jonathan Rub, et al.
Cell|July 4, 2006
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approachLars Zender, Mona S Spector, Wen Xue, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2006
Loss of p53 impedes the antileukemic response to BCR-ABL inhibitionHans-Guido Wendel, Elisa de Stanchina, Enriqué Cepero, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1)Seiji Kondo, Ying Lu, Michael Debbas, et al.
Blood|January 14, 2014
Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitorsMichael Bots, Inge Verbrugge, Benjamin P Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 26, 2024
Interferon-ε loss is elusive 9p21 link to immune-cold tumors, resistant to immune-checkpoint therapy and endogenous CXCL9/10 inductionXin Zhao, Bin Liu, William N William, et al.
Nature Genetics|March 31, 2015
Cooperative loss of RAS feedback regulation drives myeloid leukemogenesisZhen Zhao, Chi-Chao Chen, Cory D Rillahan, et al.
Cancer Discovery|May 10, 2019
A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1Evangelia Loizou, Ana Banito, Geulah Livshits, et al.
Pageof 33